Abstract
Oxidative stress as a result of either exogenous stimuli or cellular metabolism affects several cellular processes such as proliferation, apoptosis, cell death and senescence. Consequently, it is implicated in the pathogenesis of various human diseases like cancer, diabetes mellitus, atherosclerosis, neurodegenerative diseases and aging. Oxidative stress is implicated in carcinogenesis either by directly provoking DNA damage or through the regulation of intracellular signaling cascades. In both cases the cellular response to oxidative stress is determined by the cellular context. ARF, the alternative protein product of the CDKN2A locus has been recently recognized as a novel sensor of oxidative stress, in a β-catenin and Hsp70-mediated manner. Since, improved understanding of cellular responses to oxidative stress may facilitate the design of novel antineoplastic regimens, we herein review the mechanisms by which oxidative stress promotes carcinogenesis, focusing on the role of ARF as a sensor of oxidative stress.
Keywords: ARF, DNA damage, free radicals, oxidative stress, ROS/RNS, signaling, radiation, nitric oxide, peroxynitrite anion, nitrosative stress, macromolecules, oxidation, UV light, cosmic rays, chemotherapeutics
Current Molecular Medicine
Title:The Tumor Suppressor Gene ARF as a Sensor of Oxidative Stress
Volume: 12 Issue: 6
Author(s): M. Liontos, I. S. Pateras, K. Evangelou and V. G. Gorgoulis
Affiliation:
Keywords: ARF, DNA damage, free radicals, oxidative stress, ROS/RNS, signaling, radiation, nitric oxide, peroxynitrite anion, nitrosative stress, macromolecules, oxidation, UV light, cosmic rays, chemotherapeutics
Abstract: Oxidative stress as a result of either exogenous stimuli or cellular metabolism affects several cellular processes such as proliferation, apoptosis, cell death and senescence. Consequently, it is implicated in the pathogenesis of various human diseases like cancer, diabetes mellitus, atherosclerosis, neurodegenerative diseases and aging. Oxidative stress is implicated in carcinogenesis either by directly provoking DNA damage or through the regulation of intracellular signaling cascades. In both cases the cellular response to oxidative stress is determined by the cellular context. ARF, the alternative protein product of the CDKN2A locus has been recently recognized as a novel sensor of oxidative stress, in a β-catenin and Hsp70-mediated manner. Since, improved understanding of cellular responses to oxidative stress may facilitate the design of novel antineoplastic regimens, we herein review the mechanisms by which oxidative stress promotes carcinogenesis, focusing on the role of ARF as a sensor of oxidative stress.
Export Options
About this article
Cite this article as:
Liontos M., S. Pateras I., Evangelou K. and G. Gorgoulis V., The Tumor Suppressor Gene ARF as a Sensor of Oxidative Stress, Current Molecular Medicine 2012; 12 (6) . https://dx.doi.org/10.2174/156652412800792633
DOI https://dx.doi.org/10.2174/156652412800792633 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Genetics and Epidemiology of Japanese Type 1 Diabetes
Current Pharmacogenomics Hydroethanolic Extract of <i>Lampaya Medicinalis</i> Phil. (<i>Verbenaceae</i>) Decreases Proinflammatory Marker Expression in Palmitic Acid-exposed Macrophages
Endocrine, Metabolic & Immune Disorders - Drug Targets Advances in the Physiology of GPR55 in the Central Nervous System
Current Neuropharmacology The Interactions Between Diabetes Mellitus and Myelodysplastic Syndromes: Current State of Evidence and Future Directions
Current Diabetes Reviews Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases
Current Medicinal Chemistry Carbon Monoxide and Iron Modulate Plasmatic Coagulation in Alzheimer’s disease
Current Neurovascular Research Statins as Either Immunomodulators or Anti-Cancer Drugs: Functional Activities on Tumor Stromal Cells and Natural Killer Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Role of Free Fatty Acid Receptor 2 (FFAR2) in the Regulation of Metabolic Homeostasis
Current Drug Targets Recent Advancement in the Treatment of Cardiovascular Diseases: Conventional Therapy to Nanotechnology
Current Pharmaceutical Design Serum Adiponectin Levels in Patients with Familial Mediterranean Fever
Protein & Peptide Letters S-Nitrosylation: Targets, Controls and Outcomes
Current Genomics Imidazoline Receptors, Novel Agents and Therapeutic Potential
Cardiovascular & Hematological Agents in Medicinal Chemistry Mesenchymal Stem Cells: New Approaches for the Treatment of Neurological Diseases
Current Stem Cell Research & Therapy Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Current Pharmaceutical Design Nanocrystals, a New Tool to Study Lipoprotein Metabolism and Atherosclerosis
Current Pharmaceutical Biotechnology Role of Apoptosis in the Pathogenesis of Contrast Media-induced Nephropathy and Hints for its Possible Prevention by Drug Treatment
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial (Hot Topic: Achieving Current Goals in Prevention and Treatment of Vascular Disease: An Update)
Current Pharmaceutical Design An Integrated Computational Approach for Plant-Based Protein Tyrosine Phosphatase Non-Receptor Type 1 Inhibitors
Current Computer-Aided Drug Design Why is the Incidence of Type 1 Diabetes Increasing?
Current Diabetes Reviews Reacting to Stress: Radical Cellular Pathways for Novel Drug Development
Current Neurovascular Research